BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

565 related articles for article (PubMed ID: 20804749)

  • 1. Prostaglandin E2 plays a key role in the immunosuppressive properties of adipose and bone marrow tissue-derived mesenchymal stromal cells.
    Yañez R; Oviedo A; Aldea M; Bueren JA; Lamana ML
    Exp Cell Res; 2010 Nov; 316(19):3109-23. PubMed ID: 20804749
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Activated T-cells and pro-inflammatory cytokines differentially regulate prostaglandin E2 secretion by mesenchymal stem cells.
    Hegyi B; Kudlik G; Monostori E; Uher F
    Biochem Biophys Res Commun; 2012 Mar; 419(2):215-20. PubMed ID: 22333568
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Adipose tissue-derived mesenchymal stem cells are more potent suppressors of dendritic cells differentiation compared to bone marrow-derived mesenchymal stem cells.
    Ivanova-Todorova E; Bochev I; Mourdjeva M; Dimitrov R; Bukarev D; Kyurkchiev S; Tivchev P; Altunkova I; Kyurkchiev DS
    Immunol Lett; 2009 Sep; 126(1-2):37-42. PubMed ID: 19647021
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Adipose tissue-derived mesenchymal stem cells have in vivo immunosuppressive properties applicable for the control of the graft-versus-host disease.
    Yañez R; Lamana ML; García-Castro J; Colmenero I; Ramírez M; Bueren JA
    Stem Cells; 2006 Nov; 24(11):2582-91. PubMed ID: 16873762
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunomodulatory effect of human adipose tissue-derived adult stem cells: comparison with bone marrow mesenchymal stem cells.
    Puissant B; Barreau C; Bourin P; Clavel C; Corre J; Bousquet C; Taureau C; Cousin B; Abbal M; Laharrague P; Penicaud L; Casteilla L; Blancher A
    Br J Haematol; 2005 Apr; 129(1):118-29. PubMed ID: 15801964
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Adipose-tissue-derived and Wharton's jelly-derived mesenchymal stromal cells suppress lymphocyte responses by secreting leukemia inhibitory factor.
    Najar M; Raicevic G; Boufker HI; Fayyad-Kazan H; De Bruyn C; Meuleman N; Bron D; Toungouz M; Lagneaux L
    Tissue Eng Part A; 2010 Nov; 16(11):3537-46. PubMed ID: 20597819
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of immunomodulatory properties of mesenchymal stem cells derived from adult human tissues.
    Yoo KH; Jang IK; Lee MW; Kim HE; Yang MS; Eom Y; Lee JE; Kim YJ; Yang SK; Jung HL; Sung KW; Kim CW; Koo HH
    Cell Immunol; 2009; 259(2):150-6. PubMed ID: 19608159
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Human umbilical cord mesenchymal stem cells hUC-MSCs exert immunosuppressive activities through a PGE2-dependent mechanism.
    Chen K; Wang D; Du WT; Han ZB; Ren H; Chi Y; Yang SG; Zhu D; Bayard F; Han ZC
    Clin Immunol; 2010 Jun; 135(3):448-58. PubMed ID: 20207200
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [The effect of co-transplantation of bone marrow-derived mesenchymal stem cells and islet on maturation and function of bone marrow-derived dendritic cells in recipient mice].
    Li FR; Deng CY; Wang XG; Qi H; Ren LL; Zhou HX
    Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2010 Jul; 26(7):646-9. PubMed ID: 20619087
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immunosuppressive properties of cloned bone marrow mesenchymal stem cells.
    Xu G; Zhang L; Ren G; Yuan Z; Zhang Y; Zhao RC; Shi Y
    Cell Res; 2007 Mar; 17(3):240-8. PubMed ID: 17325691
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Chondrogenic differentiation alters the immunosuppressive property of bone marrow-derived mesenchymal stem cells, and the effect is partially due to the upregulated expression of B7 molecules.
    Chen X; McClurg A; Zhou GQ; McCaigue M; Armstrong MA; Li G
    Stem Cells; 2007 Feb; 25(2):364-70. PubMed ID: 17068184
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mesenchymal stromal cells use PGE2 to modulate activation and proliferation of lymphocyte subsets: Combined comparison of adipose tissue, Wharton's Jelly and bone marrow sources.
    Najar M; Raicevic G; Boufker HI; Fayyad Kazan H; De Bruyn C; Meuleman N; Bron D; Toungouz M; Lagneaux L
    Cell Immunol; 2010; 264(2):171-9. PubMed ID: 20619400
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Role of toll-like receptors on human adipose-derived stromal cells.
    Hwa Cho H; Bae YC; Jung JS
    Stem Cells; 2006 Dec; 24(12):2744-52. PubMed ID: 16902195
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mesenchymal stem cell inhibition of T-helper 17 cell- differentiation is triggered by cell-cell contact and mediated by prostaglandin E2 via the EP4 receptor.
    Duffy MM; Pindjakova J; Hanley SA; McCarthy C; Weidhofer GA; Sweeney EM; English K; Shaw G; Murphy JM; Barry FP; Mahon BP; Belton O; Ceredig R; Griffin MD
    Eur J Immunol; 2011 Oct; 41(10):2840-51. PubMed ID: 21710489
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Interferon-γ-dependent inhibition of B cell activation by bone marrow-derived mesenchymal stem cells in a murine model of systemic lupus erythematosus.
    Schena F; Gambini C; Gregorio A; Mosconi M; Reverberi D; Gattorno M; Casazza S; Uccelli A; Moretta L; Martini A; Traggiai E
    Arthritis Rheum; 2010 Sep; 62(9):2776-86. PubMed ID: 20496367
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Human mesenchymal stem cells from adipose tissue and amnion influence T-cells depending on stimulation method and presence of other immune cells.
    Kronsteiner B; Wolbank S; Peterbauer A; Hackl C; Redl H; van Griensven M; Gabriel C
    Stem Cells Dev; 2011 Dec; 20(12):2115-26. PubMed ID: 21381973
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Allogeneic mesenchymal stem cell and mesenchymal stem cell-differentiated chondrocyte suppress the responses of type II collagen-reactive T cells in rheumatoid arthritis.
    Zheng ZH; Li XY; Ding J; Jia JF; Zhu P
    Rheumatology (Oxford); 2008 Jan; 47(1):22-30. PubMed ID: 18077486
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mesenchymal stem cells inhibit lymphocyte proliferation by mitogens and alloantigens by different mechanisms.
    Rasmusson I; Ringdén O; Sundberg B; Le Blanc K
    Exp Cell Res; 2005 Apr; 305(1):33-41. PubMed ID: 15777785
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Efficacy of bone marrow-derived mesenchymal stem cells in the treatment of sclerodermatous chronic graft-versus-host disease: clinical report.
    Zhou H; Guo M; Bian C; Sun Z; Yang Z; Zeng Y; Ai H; Zhao RC
    Biol Blood Marrow Transplant; 2010 Mar; 16(3):403-12. PubMed ID: 19925878
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A critical role of IFNgamma in priming MSC-mediated suppression of T cell proliferation through up-regulation of B7-H1.
    Sheng H; Wang Y; Jin Y; Zhang Q; Zhang Y; Wang L; Shen B; Yin S; Liu W; Cui L; Li N
    Cell Res; 2008 Aug; 18(8):846-57. PubMed ID: 18607390
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 29.